Leukotriene B4 levels in sputum from asthma patients

Andrew Higham, Paul Cadden, Thomas Southworth, Matthew Rossall, Umme Kolsum, Simon Lea, Richard Knowles, D Singh

Research output: Contribution to journalArticlepeer-review


Poor asthma control is associated with increased airway neutrophils. Leukotriene B4 (LTB4) is a potent neutrophil chemoattractant. We examined the levels of LTB4 levels in the sputum of asthma patients and the relationship with disease severity. 47 asthma patients (categorised according to Global Initiative for Asthma treatment stage) and 12 healthy controls provided sputum samples that were processed first with PBS to obtain supernatants and secondly with dithiothreitol (DTT) to obtain supernatants. LTB4 levels were determined by ELISA. LTB4 levels were significantly higher in step 1 (steroid naïve) and step 3 (inhaled corticosteroid (ICS) plus long acting β-agonist) patients than step 2 patients (ICS alone) (p=0.02 and p=0.01, respectively). There was very good correlation when comparing PBS processed to DTT processed supernatants. High LTB4 levels were found in the sputum of asthmatics at step 3 despite ICS use.

Original languageEnglish
JournalEuropean Respiratory Journal Open Research
Issue number4
Early online date26 Oct 2016
Publication statusPublished - 31 Oct 2016


Dive into the research topics of 'Leukotriene B4 levels in sputum from asthma patients'. Together they form a unique fingerprint.

Cite this